EpiCypher
banner
epicypher.bsky.social
EpiCypher
@epicypher.bsky.social
Leading developer of CUT&RUN and CUT&Tag chromatin mapping assays and other tools for chromatin research. Follow us for the latest news in epigenetics.
Pinned
Just announced: CUTANA™ Fiber-seq — a game-changing platform for multiomic profiling of chromatin accessibility, DNA methylation, protein footprints, and genetic variants in a single assay.

🔗 www.epicypher.com/resources/bl...

#Epigenetics #Fiberseq #Chromatin
Coming to #PAG2026? Drop by booth 329 to chat with EpiCypher about Fiber-seq – a powerful new way to see chromatin architecture at the single-molecule level.
Ask us how it works (and get some swag).
#Fiberseq #Chromatin
January 2, 2026 at 6:00 PM
Happy New Year from all of us at EpiCypher! 🧬

Here’s to fresh experiments, better data, and bold chromatin discoveries in 2026. We’re excited to keep advancing epigenetics together.

#Epigenetics #ChromatinBiology #LabLife
January 1, 2026 at 3:00 PM
Science travel plans? 🧬
We’ve refreshed our Conference Page with 2026 booths, posters & symposia.
Start planning here: https://www.epicypher.com/resources/epigenetics-conferences/

#Epigenetics #Chromatin
December 30, 2025 at 6:00 PM
Looking to boost your drug discovery & development pipelines?

Next-generation chromatin profiling can help uncover drug mechanism of action and discover biomarkers.

Learn more:
https://www.epicypher.com/resources/blog/looking-to-boost-your-drug-discovery-and-development-pipelines-heres-how
December 29, 2025 at 6:00 PM
Cheers to a season of rest and discovery 🎉
We’re closing Dec 25 through Jan 1 for the holiday season and will be back Jan 2.
Thanks for growing the field with us this year!
#Epigenetics #LabLife
December 24, 2025 at 1:00 PM
Understanding a drug’s mechanism of action is critical for streamlining development and improving clinical success. Dave Lahr, PhD, shares how Foghorn Therapeutics uses EpiCypher's CUT&RUN Services to uncover drug MOA and accelerate development.

Read here: https://ow.ly/PCQW50XGva5
Exploring Drug Mechanism of Action with CUT&RUN Services: Q&A with Foghorn Therapeutics - EpiCypher
Disruption of epigenetic mechanisms can lead to abnormal gene expression and is linked to many diseases, including cancer, inflammation, and […]
ow.ly
December 22, 2025 at 6:00 PM
Fiber-seq: one giant leap for sequencing 🪐

A new Fierce Biotech whitepaper breaks down Fiber-seq’s origins, adoption, and the insights now within reach.

📄 Read the whitepaper: https://fb-resources.fiercebiotech.com/free/w_defa9801/?pk=LS-WP-EpiCypher-112525-listing
December 18, 2025 at 6:00 PM
🚨Holiday Shipping PSA🚨

Our last ship date for 2025 is Dec 22
Shipping resumes Jan 5, 2026

Place your orders soon—we’re here to help with planning 📦

#Epigenetics #ChromatinTools
December 17, 2025 at 8:01 PM
When your data quality matters, small workflow improvements can make a big difference.

That’s why we’ve released CUTANA™ CUT&RUN Kit Version 6 — with updates designed to improve reproducibility and streamline handling.

See what’s new in v6: https://www.epicypher.com/product/cutana-chic-cutrun-kit/
December 17, 2025 at 4:02 PM
Cheers to another year of science, teamwork, and innovation 🧬
Our 2025 holiday party reminded us how lucky we are to work with such an amazing group of scientists.
Thanks for making this journey meaningful. #Epigenetics #LabLife
December 16, 2025 at 4:01 PM
Researchers face a tough choice for DNA methylation sequencing: expensive and destructive bisulfite-seq, or limited insights from arrays, panels, and RRBS.

Read our blog to learn how meCUT&RUN avoids these pitfalls: https://www.epicypher.com/resources/blog/dna-methylation-profiling-mecutrun/
December 15, 2025 at 6:00 PM
💡 The Scientist spotlights how long-read sequencing is reshaping research of complex diseases. In a Q&A, Dr. Bryan Venters of EpiCypher explains how Fiber-seq technology is advancing the field.

📄 https://www.the-scientist.com/advances-in-long-read-sequencing-boost-epigenomic-research-73818
Advances in Long-Read Sequencing Boost Epigenomic Research
Bryan Venters of EpiCypher discusses the limitations of traditional chromatin profiling assays and explains how Fiber-seq technology overcomes these challenges.
www.the-scientist.com
December 12, 2025 at 6:01 PM
Reposted by EpiCypher
🧬🎉Join us on Dec 17th for our last session of 2025! 🎉🧬Two fantastic talks on transcriptional regulation:
🔬JB Lalanne on developmental enhancers (and starting a lab in 2025?)
🔬 @rberrens.bsky.social on transposable elements in development
📋Register here: us06web.zoom.us/webinar/regi...
December 11, 2025 at 6:54 PM
Couldn’t make it live? 🎥 The replay is now available!

Watch Zach Freeman, DVM, PhD & Emily Madden, PhD discuss how Fiber-seq + PureTarget™ uncover hidden transgene alterations.
👉 https://app.livestorm.co/epicypher/combining-fiber-seq-and-puretarget

#Epigenetics #WebinarReplay
Combining PureTarget and Fiber-seq to Discover Hidden Alterations in Genome Engineered Models | EpiCypher
Developing transgenic animal models is essential for biomedical research — but confirming that a transgene is properly integrated and active can be challenging. Traditional methods often provide on...
app.livestorm.co
December 11, 2025 at 6:00 PM
CUTANA™ Cloud — the easiest way to analyze CUT&RUN and CUT&Tag data.

No coding needed. Upload, analyze, and discover with just a few clicks.

☁️ www.epicypher.com/CUTANA-Cloud
December 10, 2025 at 6:01 PM
One experiment. Multiomic insights.

CUTANA™ Fiber-seq captures chromatin accessibility, protein footprints, DNA methylation, and more in ONE assay—saving time, samples, & budget.

Interested in Fiber-seq Services? Start here: https://www.epicypher.com/services/cutana-fiber-seq-assay-services/
December 8, 2025 at 6:01 PM
🎥 The webinar recording is now live!

Catch up on insights from Zach Freeman, DVM, PhD and Emily Madden, PhD on how Fiber-seq + PureTarget™ reveal hidden integration and expression issues.
Replay here: https://app.livestorm.co/epicypher/combining-fiber-seq-and-puretarget

#Epigenetics #Chromatin
December 4, 2025 at 6:00 PM
It’s webinar day! 🎉

Join us at 3PM EST for a deep dive into Fiber-seq + PureTarget™ with Zach Freeman, DVM, PhD and Emily Madden, PhD.
Still time to register: https://app.livestorm.co/epicypher/combining-fiber-seq-and-puretarget

#Epigenetics #GenomeEngineering
December 3, 2025 at 3:00 PM
The wait is almost over ⏳

Our webinar on Fiber-seq + PureTarget™ goes live tomorrow! Zach Freeman, DVM, PhD and Emily Madden, PhD will share new insights + tips for transgene analysis.
Grab your spot: https://app.livestorm.co/epicypher/combining-fiber-seq-and-puretarget

#Epigenetics #CRISPR
December 2, 2025 at 4:00 PM
Reposted by EpiCypher
🔔Join us next Wednesday for #FragileNucleosome! 2 fantastic talks on chromatin regulation:🔬 @mariamafau.bsky.social on ZIC2's dual role in neural induction 🔬 @jhenninger.bsky.social on how RNA-binding proteins drive transcription
📋Register here for the entire series: us06web.zoom.us/webinar/regi...
November 26, 2025 at 10:16 AM
Grateful for every scientist mapping the epigenome, sharing data, or troubleshooting at midnight. Whether you’re celebrating Thanksgiving or not, thanks for being part of our community 🧬💡 #Epigenetics #ScienceLife
November 27, 2025 at 3:01 PM
🚨 One-week countdown!

Don’t miss this free webinar on Fiber-seq + PureTarget™ for uncovering transgene integration and regulation issues.

📆 Dec 3 @ 3PM EST – sign up here: https://app.livestorm.co/epicypher/combining-fiber-seq-and-puretarget

#Epigenetics #CRISPR
November 26, 2025 at 6:00 PM
How do reader proteins interact with chromatin to regulate biological processes?

📢 A new study shows how nucleosome context shapes chromatin reader specificity — a key insight for understanding disease mechanisms & therapeutic targeting.

📄 Read here: https://pubmed.ncbi.nlm.nih.gov/41182902/
November 25, 2025 at 6:30 PM
Reposted by EpiCypher
Explore CUT&RUN, a revolutionary epigenomic mapping tool for understanding the role of the epigenome in scientific research, with @epicypher.bsky.social
humangenetics.ucsf.edu/ucsf-ihg-cat...
November 24, 2025 at 9:52 PM